Cargando…
It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828818/ https://www.ncbi.nlm.nih.gov/pubmed/31736876 http://dx.doi.org/10.3389/fendo.2019.00738 |
Sumario: |
---|